Back to User profile » Dr Jinxing Hu
Papers published by Dr Jinxing Hu:
Risk of All-Cause Mortality in Mild Chronic Obstructive Pulmonary Disease: Evidence From the NHANES III and 2007–2012
Zou W, Ou J, Wu F, Xiao S, Deng Z, Li H, Wang Z, Tang G, Liu S, Ye D, Zhu D, Hu J, Ran P
International Journal of Chronic Obstructive Pulmonary Disease 2025, 20:217-229
Published Date: 30 January 2025
Characterization of Genetic Variants Associated with Rifampicin Resistance Level in Mycobacterium tuberculosis Clinical Isolates Collected in Guangzhou Chest Hospital, China
Hameed HMA, Fang C, Liu Z, Ju Y, Han X, Gao Y, Wang S, Chiwala G, Tan Y, Guan P, Hu J, Xiong X, Peng J, Lin Y, Hussain M, Zhong N, Maslov DA, Cook GM, Liu J, Zhang T
Infection and Drug Resistance 2022, 15:5655-5666
Published Date: 27 September 2022
PM2.5 Induces Airway Remodeling in Chronic Obstructive Pulmonary Diseases via the Wnt5a/β-Catenin Pathway
Zou W, Wang X, Sun R, Hu J, Ye D, Bai G, Liu S, Hong W, Guo M, Ran P
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3285-3295
Published Date: 3 December 2021
GSK-3β Inhibitors Attenuate the PM2.5-Induced Inflammatory Response in Bronchial Epithelial Cells
Zou W, Ye D, Liu S, Hu J, Zhu T, He F, Ran P
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:2845-2856
Published Date: 14 October 2021
Concomitant Pulmonary Tuberculosis Impair Survival in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Lung Adenocarcinoma Patients Receiving EGFR-Tyrosine Kinase Inhibitor
Xie Y, Su N, Zhou W, Lei A, Li X, Li W, Huang Z, Cen W, Hu J
Cancer Management and Research 2021, 13:7517-7526
Published Date: 1 October 2021
PM2.5 Induces the Expression of Inflammatory Cytokines via the Wnt5a/Ror2 Pathway in Human Bronchial Epithelial Cells
Zou W, Wang X, Hong W, He F, Hu J, Sheng Q, Zhu T, Ran P
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:2653-2662
Published Date: 23 October 2020